Lithium Ion

Lithium Ion

SCHEMBL7703313

COc1ccc([C@@H]2c3ccc(OC)cc3CC[C@@H]2CN(C)CC(=O)[O-])cc1.[Li+]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 3/20 0.74
PPARD Q03181 2/20 0.41
HSD17B2 P37059 2/20 0.39
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
ACHE P22303 2/20 0.38
CYP19A1 P11511 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
TAS2R14 Q9NYV8 1/20 0.37
SRD5A1 P18405 2/20 0.36
MTNR1A P48039 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL7706037 0.94 SLC6A9 (0.69) SLC6A9PPARDHSD17B2CA1CA2
Org-25935 SCHEMBL7704305 0.94 SLC6A9 (0.85) SLC6A9PPARDCA1CA2CA7
Org-25935 SCHEMBL7703028 0.94 SLC6A9 (0.85) SLC6A9PPARDCA1CA2CA7
Lithium Ion SCHEMBL7706192 0.90 SLC6A9 (0.64) SLC6A9PPARDHSD17B2CA1CA2
Lithium Ion SCHEMBL7706983 0.86 SLC6A9 (0.71) SLC6A9TAS2R14MTNR1A
Lithium Ion SCHEMBL7704515 0.85 SLC6A9 (0.60) SLC6A9PPARDHSD17B2CA1CA2
Org-25935 SCHEMBL1761267 0.85 SLC6A9 (1.00) SLC6A9PPARDCA1CA2CA7
Org-25935 SCHEMBL27034881 0.85 SLC6A9 (1.00) SLC6A9PPARDCA1CA2CA7
Org-25935 SCHEMBL7703430 0.85 SLC6A9 (1.00) SLC6A9PPARDCA1CA2CA7
Lithium Ion SCHEMBL7700187 0.85 SLC6A9 (0.70) SLC6A9PPARDMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed